Share This Page
Drug Price Trends for AMOX-CLAV
✉ Email this page to a colleague
Average Pharmacy Cost for AMOX-CLAV
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| AMOX-CLAV 875-125 MG TABLET | 81964-0221-01 | 0.27322 | EACH | 2025-01-01 |
| AMOX-CLAV 200-28.5 MG/5 ML SUS | 00781-6102-57 | 0.05689 | ML | 2024-12-18 |
| AMOX-CLAV 200-28.5 MG/5 ML SUS | 00143-9981-75 | 0.05689 | ML | 2024-12-18 |
| AMOX-CLAV 200-28.5 MG/5 ML SUS | 00781-6102-52 | 0.06203 | ML | 2024-12-18 |
| AMOX-CLAV 200-28.5 MG/5 ML SUS | 00093-2277-73 | 0.05807 | ML | 2024-12-18 |
| AMOX-CLAV ER 1,000-62.5 MG TAB | 00781-1943-82 | 5.43955 | EACH | 2024-12-18 |
| AMOX-CLAV 200-28.5 MG/5 ML SUS | 00143-9981-01 | 0.05807 | ML | 2024-12-18 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Amoxicillin-Clavulanate (AMOX-CLAV)
Introduction to Amoxicillin-Clavulanate
Amoxicillin-clavulanate, commonly known by the brand name Augmentin, is a combination antibiotic used to treat a variety of bacterial infections, including pneumonia, bronchitis, and urinary tract infections. It belongs to the class of β-lactam antibiotics and is widely prescribed due to its broad-spectrum efficacy.
Market Size and Growth
The global market for amoxicillin, which includes amoxicillin-clavulanate, has been experiencing steady growth. As of 2023, the amoxicillin market size was valued at approximately $4.58 billion and is projected to grow to $4.74 billion in 2024, with a compound annual growth rate (CAGR) of 3.4%[1].
By 2028, the market is expected to reach $5.44 billion at a CAGR of 3.5%, driven by factors such as enhanced knowledge of antibiotics, increased research activities, and a growing elderly population[1].
Regional Market Analysis
The demand for amoxicillin-clavulanate varies across different regions:
- North America: This region is expected to be one of the highest-growing markets due to significant investments in clinical trials and research and development (R&D)[3].
- Europe: Europe follows closely behind North America in terms of market growth.
- Asia Pacific: This region is anticipated to have the highest CAGR due to a large patient population at risk of bacterial infections, largely attributed to unhygienic conditions and lack of safe drinking water[3].
- Latin America and Middle East & Africa: These regions also face high risks of bacterial infections due to poor hygiene and lack of safe water, contributing to the demand for amoxicillin-clavulanate[3].
Factors Driving Market Growth
Several factors are driving the growth of the amoxicillin-clavulanate market:
- Increased Healthcare Expenditure: Rising healthcare expenditure ensures wider accessibility and availability of the drug, leading to higher prescription rates and improved patient outcomes. For instance, healthcare expenditure in the US increased by 4.1% in 2022 to reach $4.5 trillion[1].
- Rising Incidences of Bacterial Infections: The growing number of bacterial infections, particularly in developing and low-income countries, is a major driver of the market[3].
- Innovative Formulations: Major companies are developing innovative drugs, such as reformulated versions of vonoprazan tablets, to enhance treatment outcomes for infections like Helicobacter pylori[1].
Price Projections and Current Pricing
Current Pricing
The cost of amoxicillin-clavulanate can vary based on the dosage and form of the medication:
- Oral Tablets: For example, 20 tablets of 875 mg-125 mg amoxicillin-clavulanate can cost around $86 without insurance, or approximately $4 per pill. However, with discount programs, the cost can be significantly reduced, such as to $7 per 20 tablets[5].
- Oral Powder for Reconstitution: Prices range from $15.66 for 50 milliliters of 200 mg-28.5 mg/5 mL to $44.65 for 200 milliliters of 600 mg-42.9 mg/5 mL[2].
Price Projections
Given the steady growth rate of the amoxicillin market, prices are likely to remain relatively stable or see minor adjustments:
- Generic vs. Brand Name: Generic versions of amoxicillin-clavulanate are generally cheaper than brand-name versions. For instance, generic amoxicillin-clavulanate can cost as low as $7 per 20 tablets, compared to $464 for brand-name Augmentin[5].
- Discount Programs: The use of discount cards and programs can significantly reduce the cost of the medication, making it more accessible to a wider population[2].
Challenges and Opportunities
Challenges
- Resistance to Antibiotics: The increasing resistance to antibiotics is a significant challenge facing the amoxicillin-clavulanate market. This resistance can reduce the efficacy of the drug and limit its use[3].
- Regulatory Hurdles: Strict regulatory environments can slow down the approval and launch of new formulations, impacting market growth.
Opportunities
- Emerging Markets: The growing demand in emerging markets, particularly in the Asia Pacific region, presents a significant opportunity for market expansion[3].
- Innovative Formulations: The development of new and innovative formulations, such as combination therapies and immunotherapy, can enhance treatment outcomes and drive market growth[1].
Key Takeaways
- The amoxicillin-clavulanate market is expected to grow steadily, driven by increased healthcare expenditure, rising incidences of bacterial infections, and innovative formulations.
- Regional markets, especially in North America and the Asia Pacific, are anticipated to see significant growth.
- Prices are likely to remain stable, with generic versions offering cost-effective alternatives.
- Challenges such as antibiotic resistance and regulatory hurdles need to be addressed to fully capitalize on market opportunities.
FAQs
Q: What is the current market size of the amoxicillin-clavulanate market? A: As of 2023, the amoxicillin market size was valued at approximately $4.58 billion[1].
Q: What is the projected growth rate of the amoxicillin-clavulanate market? A: The market is expected to grow at a CAGR of 3.4% from 2023 to 2024 and 3.5% from 2023 to 2028[1].
Q: Which regions are expected to see the highest growth in the amoxicillin-clavulanate market? A: North America and the Asia Pacific region are expected to see significant growth due to investments in R&D and a large patient population at risk of bacterial infections, respectively[3].
Q: How much does amoxicillin-clavulanate cost without insurance? A: Without insurance, 20 tablets of 875 mg-125 mg amoxicillin-clavulanate can cost around $86, or approximately $4 per pill[5].
Q: Are there any discount programs available for amoxicillin-clavulanate? A: Yes, discount cards and programs can significantly reduce the cost of the medication, making it more accessible to a wider population[2].
Sources
- GlobeNewswire: "Amoxicillin Market Research Report 2024: Combination Therapies and Immunotherapy Trends Shaping Future Landscape - Global Long-term Forecast to 2028 and 2033"[1].
- Drugs.com: "Amoxicillin/clavulanate Prices, Coupons, Copay Cards & Patient Assistance Programs"[2].
- Reports and Data: "Amoxicillin Market Share, Analysis | Growth Report, 2020-2028"[3].
- IndustryARC: "Amoxicillin Market Size Report, 2023 - 2030"[4].
- SingleCare: "How much is Augmentin (amoxicillin-pot clavulanate) without insurance?"[5].
More… ↓
